Alnylam Pharmaceuticals
ALNY
ALNY
258 hedge funds and large institutions have $5.24B invested in Alnylam Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 82 increasing their positions, 83 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
4% more funds holding
Funds holding: 248 → 258 (+10)
1% less repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 83
Holders
258
Holding in Top 10
9
Calls
$65.5M
Puts
$37.2M
Top Buyers
| 1 | +$187M | |
| 2 | +$20.1M | |
| 3 | +$17.7M | |
| 4 |
Goldman Sachs
New York
|
+$16.9M |
| 5 |
Los Angeles Capital Management
Los Angeles,
California
|
+$10.9M |
Top Sellers
| 1 | -$18.6M | |
| 2 | -$15.7M | |
| 3 | -$13.1M | |
| 4 |
UBS AM
Chicago,
Illinois
|
-$9.77M |
| 5 |
ZBI
Ziff Brothers Investments
New York
|
-$7.73M |